IceCure Medical Return on Equity (ROE) Growth & History (ICCM)

IceCure Medical's return on equity was −188.78% for fiscal 2025.

View full IceCure Medical company overview

IceCure Medical annual return on equity history

IceCure Medical annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20252025-12-31−188.78%−28.08 pp
20242024-12-31−160.70%−82.73 pp
20232023-12-31−77.97%−13.14 pp
20222022-12-31−64.83%−4.13 pp
20212021-12-31−60.69%+22.76 pp
20202020-12-31−83.45%

IceCure Medical return on equity trends

Over the last five fiscal years, IceCure Medical's return on equity decreased from −83.45% to −188.78%, a change of −105.32 percentage points. The latest reported quarter, Q2 2026, shows −44.15%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review IceCure Medical source filings ↗

Community posts

It’s quiet here.

No posts about ICCM yet. Start the conversation.

Write the first post